Consistent with 4T1 R model, inhibition of Usp22 in LLC1 cells, a well-established syngeneic tumor model that is resistant to ICB (31), inhibited tumor growth (Supplemental Figure 15, A and B). Here, USP22 is linked to neoplasm.